Growth Metrics

Emergent BioSolutions (EBS) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Emergent BioSolutions (EBS) over the last 16 years, with Q3 2025 value amounting to $51.2 million.

  • Emergent BioSolutions' Income towards Parent Company fell 5540.07% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 13635.06%. This contributed to the annual value of -$190.6 million for FY2024, which is 7493.75% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Income towards Parent Company is $51.2 million, which was down 5540.07% from -$12.0 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Income towards Parent Company peaked at $177.9 million during Q4 2021, and registered a low of -$283.1 million during Q2 2024.
  • For the 5-year period, Emergent BioSolutions' Income towards Parent Company averaged around -$44.1 million, with its median value being -$31.3 million (2024).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 65760.0% in 2021, then plummeted by 493243.24% in 2023.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Income towards Parent Company stood at $177.9 million in 2021, then tumbled by 137.66% to -$67.0 million in 2022, then rose by 26.12% to -$49.5 million in 2023, then soared by 36.77% to -$31.3 million in 2024, then skyrocketed by 263.58% to $51.2 million in 2025.
  • Its Income towards Parent Company stands at $51.2 million for Q3 2025, versus -$12.0 million for Q2 2025 and $68.0 million for Q1 2025.